Filing Details

Accession Number:
0000711377-10-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-01 18:37:24
Reporting Period:
2010-09-29
Filing Date:
2010-10-01
Accepted Time:
2010-10-01 18:37:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189001 H Thomas Reed Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-29 1,868 $6.75 3,556 No 4 M Direct
Common Stock Disposition 2010-09-29 1,868 $34.39 1,688 No 4 S Direct
Common Stock Acquisiton 2010-09-30 7 $6.75 1,695 No 4 M Direct
Common Stock Disposition 2010-09-30 7 $34.14 1,688 No 4 S Direct
Common Stock Acquisiton 2010-09-30 1,284 $9.09 2,972 No 4 M Direct
Common Stock Disposition 2010-09-30 1,284 $34.14 1,688 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option (Right to buy) Disposition 2010-09-29 1,868 $0.00 1,868 $6.75
Common Stock Common Stock Options (Right to buy) Disposition 2010-09-30 7 $0.00 7 $6.75
Common Stock Common Stock Option (Right to buy) Disposition 2010-09-30 1,284 $0.00 1,284 $9.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,507 2013-10-10 No 4 M Direct
19,500 2013-10-10 No 4 M Direct
18,216 2014-12-21 No 4 M Direct
Footnotes
  1. The options were granted 10/10/03 as non-qualified options with 10 year lives. The options vested 33% yearly for 3 years.
  2. The options were granted 12/21/04 as non-qualified options with 10 year lives. The options vested 33% per year for 3 years